Stock Rating Upgrade The Value Trend Rating for Resmed Inc (NYSE: RMD) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]
Stock Rating Downgrade The Value Trend Rating for Resmed Inc (NYSE: RMD) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Resmed Inc (NYSE: RMD) has reported earnings for its second fiscal quarter (ending December 31) of $2.35 versus $1.42 for the same period a year ago — an increase of 65%. For the latest four […]
Resmed Inc (NYSE: RMD) has reported E.P.S. of $2.12 for its first fiscal quarter (ending September 30) versus $1.49 for the same period a year ago — an increase of 42%. E.P.S. were $7.57 for […]
Resmed Inc (NYSE: RMD) has recently enjoyed extremely meaningful positive changes in investment behavior: positive upside/downside volume developed, and the stock’s recent price rise disrupted its longer term downtrend. Significant positive changes in fundamentals have […]
Resmed Inc (NYSE: RMD) has reported E.P.S. of $1.99 for its fourth fiscal quarter (ending June 30) versus $1.56 for the same period a year ago. For the latest four quarters through June 30, E.P.S. […]
Resmed Inc (NYSE: RMD) stock closed at $182.20 on 6/24/24 after a major decline of -11.5%. Moreover, trading volume in this decline was exceptionally high at 346% of normal. Relative to the market the stock […]
Resmed Inc (NYSE: RMD). Meaningful positive changes in fundamentals have recently occurred: the consensus estimate for June, 2024 increased significantly, the stock’s power rating rose above 70, and the consensus estimate for June, 2025 increased […]
Meaningful positive changes in Resmed Inc (NYSE: RMD) fundamentals have recently occurred: the consensus estimate for June, 2024 increased significantly, the stock’s power rating rose above 70, and the consensus estimate for June, 2025 increased […]
On 4/26/24, Resmed Inc (NYSE: RMD) stock enjoyed a major increase of 18.9%, closing at $218.06. Moreover, exceptionally high trading volume at 380% of normal accompanied the advance. Relative to the market the stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research